We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01328522
Recruitment Status : Completed
First Posted : April 4, 2011
Last Update Posted : October 24, 2011
Regeneron Pharmaceuticals
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2011
  Study Completion Date : September 2011